Lutikizumab 300 mg was shown to be more effective than placebo in HS patients.

A new study from Northwestern University in Chicago has identified a concerning trend in the accuracy of skin disease diagnosis across...

Apremilast is effective for the treatment of moderate-to-severe plaque psoriasis short-term in pediatric patients.

Dr. Tashmeeta Ahad has been awarded the first Dr. Mercy Alexis Research Grant in Skin of Color Dermatology for her project on...

Morbilliform eruptions of viral exanthems are common in the pediatric in-patient setting, and several possible diagnoses can be suspected...

Plaque psoriasis patients with lower blood monocyte counts at baseline achieved early response when treated with secukinumab.

Phase III results presented during a late-breaking session at the annual meeting of the American Academy of Dermatology in San Diego,...

Testing by Valisure, an independent pharmaceutical quality assurance company, has shown that benzene—a known human carcinogen—can form at...